Literature DB >> 20138079

Interspecies differences in metabolism of arsenic by cultured primary hepatocytes.

Zuzana Drobná1, Felecia S Walton, Anne W Harmon, David J Thomas, Miroslav Stýblo.   

Abstract

Biomethylation is the major pathway for the metabolism of inorganic arsenic (iAs) in many mammalian species, including the human. However, significant interspecies differences have been reported in the rate of in vivo metabolism of iAs and in yields of iAs metabolites found in urine. Liver is considered the primary site for the methylation of iAs and arsenic (+3 oxidation state) methyltransferase (As3mt) is the key enzyme in this pathway. Thus, the As3mt-catalyzed methylation of iAs in the liver determines in part the rate and the pattern of iAs metabolism in various species. We examined kinetics and concentration-response patterns for iAs methylation by cultured primary hepatocytes derived from human, rat, mice, dog, rabbit, and rhesus monkey. Hepatocytes were exposed to [(73)As]arsenite (iAs(III); 0.3, 0.9, 3.0, 9.0 or 30 nmol As/mg protein) for 24 h and radiolabeled metabolites were analyzed in cells and culture media. Hepatocytes from all six species methylated iAs(III) to methylarsenic (MAs) and dimethylarsenic (DMAs). Notably, dog, rat and monkey hepatocytes were considerably more efficient methylators of iAs(III) than mouse, rabbit or human hepatocytes. The low efficiency of mouse, rabbit and human hepatocytes to methylate iAs(III) was associated with inhibition of DMAs production by moderate concentrations of iAs(III) and with retention of iAs and MAs in cells. No significant correlations were found between the rate of iAs methylation and the thioredoxin reductase activity or glutathione concentration, two factors that modulate the activity of recombinant As3mt. No associations between the rates of iAs methylation and As3mt protein structures were found for the six species examined. Immunoblot analyses indicate that the superior arsenic methylation capacities of dog, rat and monkey hepatocytes examined in this study may be associated with a higher As3mt expression. However, factors other than As3mt expression may also contribute to the interspecies differences in the hepatocyte capacity to methylate iAs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138079      PMCID: PMC2862857          DOI: 10.1016/j.taap.2010.01.015

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  31 in total

1.  Liberation and analysis of protein-bound arsenicals.

Authors:  M Styblo; M F Hughes; D J Thomas
Journal:  J Chromatogr B Biomed Appl       Date:  1996-02-23

2.  Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes.

Authors:  R M Kagan; S Clarke
Journal:  Arch Biochem Biophys       Date:  1994-05-01       Impact factor: 4.013

3.  Preparation and purification of 74As-labeled arsenate and arsenite for use in biological experiments.

Authors:  P F Reay; C J Asher
Journal:  Anal Biochem       Date:  1977-04       Impact factor: 3.365

4.  A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol.

Authors:  Shan Lin; Qing Shi; F Brent Nix; Miroslav Styblo; Melinda A Beck; Karen M Herbin-Davis; Larry L Hall; Josef B Simeonsson; David J Thomas
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

Review 5.  Metabolism of arsenic in human liver: the role of membrane transporters.

Authors:  Zuzana Drobná; Felecia S Walton; David S Paul; Weibing Xing; David J Thomas; Miroslav Stýblo
Journal:  Arch Toxicol       Date:  2009-12-18       Impact factor: 5.153

6.  Lack of methylation of inorganic arsenic in the chimpanzee.

Authors:  M Vahter; R Couch; B Nermell; R Nilsson
Journal:  Toxicol Appl Pharmacol       Date:  1995-08       Impact factor: 4.219

7.  Identification of methylated metabolites of inorganic arsenic by thin-layer chromatography.

Authors:  M Stýblo; M Delnomdedieu; M F Hughes; D J Thomas
Journal:  J Chromatogr B Biomed Appl       Date:  1995-06-09

8.  Elucidating the pathway for arsenic methylation.

Authors:  David J Thomas; Stephen B Waters; Miroslav Styblo
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

9.  Comparative in vitro methylation of trivalent and pentavalent arsenicals.

Authors:  M Styblo; H Yamauchi; D J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  1995-12       Impact factor: 4.219

10.  Reduction and binding of arsenate in marmoset monkeys.

Authors:  M Vahter; E Marafante
Journal:  Arch Toxicol       Date:  1985-06       Impact factor: 5.153

View more
  13 in total

1.  A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh.

Authors:  Kristin N Harper; Xinhua Liu; Megan N Hall; Vesna Ilievski; Julie Oka; Larissa Calancie; Vesna Slavkovich; Diane Levy; Abu Siddique; Shafiul Alam; Jacob L Mey; Alexander van Geen; Joseph H Graziano; Mary V Gamble
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

2.  Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells.

Authors:  Kostiantyn Dreval; Volodymyr Tryndyak; Iryna Kindrat; Nathan C Twaddle; Orish Ebere Orisakwe; Thilak K Mudalige; Frederick A Beland; Daniel R Doerge; Igor P Pogribny
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

3.  Fluorescence based cell counting in collagen monolayer cultures of primary hepatocytes.

Authors:  C Priesnitz; S Sperber; R Garg; M Orsini; F Noor
Journal:  Cytotechnology       Date:  2014-11-26       Impact factor: 2.058

4.  Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure.

Authors:  Matthew O Gribble; Wan-Yee Tang; Yan Shang; Jonathan Pollak; Jason G Umans; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Eliseo Guallar; Shelley A Cole; M Daniele Fallin; Ana Navas-Acien
Journal:  Arch Toxicol       Date:  2013-10-24       Impact factor: 5.153

5.  Associations of plasma selenium with arsenic and genomic methylation of leukocyte DNA in Bangladesh.

Authors:  J Richard Pilsner; Megan N Hall; Xinhua Liu; Habibul Ahsan; Vesna Ilievski; Vesna Slavkovich; Diane Levy; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble
Journal:  Environ Health Perspect       Date:  2011-01       Impact factor: 9.031

6.  Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity.

Authors:  Megan N Hall; Mary V Gamble
Journal:  J Toxicol       Date:  2012-03-14

7.  Chronic arsenic exposure and blood glutathione and glutathione disulfide concentrations in Bangladeshi adults.

Authors:  Megan N Hall; Megan Niedzwiecki; Xinhua Liu; Kristin N Harper; Shafiul Alam; Vesna Slavkovich; Vesna Ilievski; Diane Levy; Abu B Siddique; Faruque Parvez; Jacob L Mey; Alexander van Geen; Joseph Graziano; Mary V Gamble
Journal:  Environ Health Perspect       Date:  2013-06-21       Impact factor: 9.031

8.  Differential binding of monomethylarsonous acid compared to arsenite and arsenic trioxide with zinc finger peptides and proteins.

Authors:  Xixi Zhou; Xi Sun; Charlotte Mobarak; A Jay Gandolfi; Scott W Burchiel; Laurie G Hudson; Ke Jian Liu
Journal:  Chem Res Toxicol       Date:  2014-03-19       Impact factor: 3.739

9.  Lipid Metabolism Alterations in a Rat Model of Chronic and Intergenerational Exposure to Arsenic.

Authors:  Cesar Rivas-Santiago; Irma González-Curiel; Sergio Zarazua; Michael Murgu; Alonso Ruiz Cardona; Blanca Lazalde; Edgar E Lara-Ramírez; Edgar Vázquez; Julio Enrique Castañeda-Delgado; Bruno Rivas-Santiago; Jesús Adrián Lopez; Alberto R Cervantes-Villagrana; Yamilé López-Hernández
Journal:  Biomed Res Int       Date:  2019-10-15       Impact factor: 3.411

10.  Proanthocyanidins Antagonize Arsenic-Induced Oxidative Damage and Promote Arsenic Methylation through Activation of the Nrf2 Signaling Pathway.

Authors:  Mengchuan Xu; Qiang Niu; Yunhua Hu; Gangling Feng; Haixia Wang; Shugang Li
Journal:  Oxid Med Cell Longev       Date:  2019-01-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.